NanoString Says Doubled Award Would Be 'Death Sentence'
Seattle biotech NanoString Technologies Inc. has told a Delaware court that if rival 10x Genomics' request to double a $31 million award in a jury's November finding of willful infringement is...To view the full article, register now.
Already a subscriber? Click here to view full article